Download full-text PDF |
Source |
---|
J Nutr Health Aging
January 2025
Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Department of Geriatrics and Orthopedics, Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address:
J Nutr Health Aging
January 2025
Gazi University, School of Medicine, Department of Internal Medicine, Division of Geriatrics, Ankara, Turkey.
Biomed Environ Sci
November 2024
NHC Key Laboratory of Pneumoconiosis; Shanxi Key Laboratory of Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, The First Hospital of Shanxi Medical University, Taiyuan 030000, Shanxi, China.
Prim Care Diabetes
October 2024
The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China. Electronic address:
Arthritis Res Ther
February 2024
Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Background: Rheumatoid arthritis (RA) is typically preceded by an extended preclinical period where circulating autoantibodies, particularly anti-citrullinated protein antibodies (ACPA), are detectable in the absence of clinical arthritis. Increased dietary intake of anti-inflammatory omega-3 (ω3) polyunsaturated fatty acids (PUFA) has been shown to be associated with a lower the risk of developing incident RA in large epidemiological studies. It is currently not known how changes in fatty acid (FA) metabolism may impact on the progression towards RA in at-risk individuals.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!